InsiderTradesSIGMA

InsidersTradesSigma

← Executives ★ Sign in to follow

RY

Rozov Yadin

Director

BoardM

Oramed Pharmaceuticals INC.Midwest Holding INC.Dave Inc./DE Core Scientific, Inc./tx

Cumul. flow

0

Total declarations

0

Companies

€1m

▲ Purchases (5 ops.)

€3m

▼ Sales (4 ops.)

Insider track record

Board Director

Disclosed buys

5

Disclosed sells

4

T+90 hit rate

43%

T+90 mean return

+41.9%

Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Discover the complete record of transactions filed by Rozov Yadin, Director. Insider active across 4 companies, notably Oramed Pharmaceuticals INC.. In total, 27 reports have been published. Breakdown: 5 buys · 4 sells. Total volume traded: €4.5m. History available since 14 June 2022. The latest transaction was filed on 5 June 2026 (Don). Regulator: SEC (Form 4). The full history is free.

Companies and markets linked to Rozov Yadin

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Oramed Pharmaceuticals INC. (US)Midwest Holding INC. (US)Dave Inc./DE (US)Core Scientific, Inc./tx (US)

Declarations27 total

●

DirectorExecutives5 Jun 2026Dave Inc./DE

2,200 shares0Class A Common StockSEC:0001193125-26-263065:0

◆

DirectorExecutives2 Jun 2026Dave Inc./DE

637 shares0Class A Common StockSEC:0001193125-26-257854:0

◆

DirectorExecutives4 Feb 2026Core Scientific, Inc./tx

18,575 shares0Common StockSEC:0000905148-26-000549:0

●

DirectorExecutives30 Dec 2025Core Scientific, Inc./tx

40,100 shares0Common StockSEC:0000905148-26-000005:0

▼

DirectorExecutives12 Sept 2025Dave Inc./DE

3 shares@ US$225.210.0% of flowClass A Common StockSEC:0000950170-25-114621:0

▼

DirectorExecutives4 Sept 2025Dave Inc./DE

$324,81642SEC ↗

1,659 shares@ US$195.7920.5% of flowClass A Common StockSEC:0000950170-25-113312:0

●

DirectorExecutives10 Jun 2025Dave Inc./DE

2,200 shares0Class A Common StockSEC:0000950170-25-084877:0

◆

DirectorExecutives2 Jun 2025Dave Inc./DE

1,105 shares0Class A Common StockSEC:0000950170-25-083385:0

▼

DirectorExecutives4 Jun 2025Dave Inc./DE

5,400 shares@ US$206.9290.4% of flowClass A Common StockSEC:0000950170-25-082415:0

▲

DirectorExecutives28 May 2025Core Scientific, Inc./tx

110,000 shares@ US$10.867Common StockSEC:0000905148-25-001941:0

Canonical exit: 26 Aug 2025 (T+90)

◆

DirectorExecutives27 Jan 2025Core Scientific, Inc./tx

20,448 shares0Common StockSEC:0000905148-25-000232:0

▼

DirectorExecutives22 Nov 2024Core Scientific, Inc./tx

105,000 shares@ US$18.113888.9% of flowCommon StockSEC:0000905148-24-003266:0

●

DirectorExecutives11 Nov 2024Core Scientific, Inc./tx

$1,95017SEC ↗

195,000 shares@ US$0.010.1% of flowCommon StockSEC:0000905148-24-003021:0

◆

DirectorExecutives3 Jun 2024Dave Inc./DE

4,726 shares0Class A Common StockSEC:0000950172-24-000328:0

◆

DirectorExecutives27 May 2024Core Scientific, Inc./tx

127,446 shares0Common StockSEC:0000905148-24-001643:0

▲

DirectorExecutives15 Mar 2024Core Scientific, Inc./tx

$245,96834SEC ↗

80,000 shares@ US$3.074611.1% of flowCommon StockSEC:0000905148-24-000971:0

Canonical exit: 13 Jun 2024 (T+90)

▲

DirectorExecutives7 Mar 2024Dave Inc./DE

$29,84820SEC ↗

800 shares@ US$37.3126.5% of flowClass A Common StockSEC:0001096906-24-000381:0

Canonical exit: 5 Jun 2024 (T+90)

◆

DirectorExecutives4 Jan 2024Oramed Pharmaceuticals INC.

30,000 sharesCommon StockSEC:0001209191-24-001141:0

●

DirectorExecutives20 Dec 2023Midwest Holding INC.

$611,84719SEC ↗

22,661 shares@ US$27.00100.0% of flowCommon StockSEC:0001104659-23-128205:0

▲

DirectorExecutives4 Dec 2023Dave Inc./DE

$82,76022SEC ↗

12,941 shares@ US$6.395273.5% of flowClass A Common StockSEC:0001209191-23-057680:0

Canonical exit: 3 Mar 2024 (T+90)

◆

DirectorExecutives6 Jul 2023Dave Inc./DE

30,239 shares0Class A Common StockSEC:0001209191-23-041962:0

◆

DirectorExecutives6 Jun 2023Midwest Holding INC.

1,164 shares0Common StockSEC:0001921268-23-000003:0

◆

DirectorExecutives17 Apr 2023Oramed Pharmaceuticals INC.

30,000 sharesCommon StockSEC:0001209191-23-024938:0

▲

DirectorExecutives13 Mar 2023Oramed Pharmaceuticals INC.

$39,12038SEC ↗

20,000 shares@ US$1.956100.0% of flowCommon StockSEC:0001209191-23-018944:0

Canonical exit: 11 Jun 2023 (T+90)

◆

DirectorExecutives28 Jul 2022Oramed Pharmaceuticals INC.

12,000 sharesCommon StockSEC:0001209191-22-043772:0

25 of 27 declarations

About Rozov Yadin

Rozov Yadin is a Board Member at Oramed Pharmaceuticals Inc. and Midwest Holding Inc. He brings his expertise to the board, participating in strategy development and oversight of the company's performance.